← Evidence map

ArticleFrontiers in pharmacology2021

Sodium-Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK-mTOR Signaling Pathway-Mediated Autophagy.

Changzhen Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

57 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33995090